Resources

As a service to healthcare professionals and to help facilitate annual influenza vaccination programs, provided below are in-office educational materials to support patient education on the benefits of influenza immunization.

	Office Poster Show your commitment towards the fight against influenza – while encouraging your patients to be immunized against the flu - by displaying this in-office poster. Download PDF English (260 KB)
	Patient Brochure Provide information to your patients about the need to be immunized against influenza and how Afluria^® vaccine can help. Download PDF English (807 KB)
	Flu Tips Learn about the benefits of Afluria^® vaccine. Download PDF English (658 KB)
	Afluria^® Product Monograph Find information about the seriousness of influenza disease and details about CSL Biotherapies and Afluria^® vaccine. Download PDF English (2.1 MB)

Important Safety Information

Afluria^® is indicated for active immunization of persons 18 years of age and older against influenza disease caused by influenza virus subtypes A and type B present in the vaccine. The indication is based on the immune response elicited by Afluria^®; no controlled clinical studies have demonstrated a decrease in influenza disease after vaccination with Afluria^®.

Afluria^® should not be administered to individuals with hypersensitivity to eggs or chicken protein or other components of Afluria^®, or to anyone who has had a life-threatening reaction to previous influenza vaccination. The most common injection-site adverse reactions were tenderness, pain, redness, and swelling. The most common systemic adverse reactions were headache, malaise, and muscle aches.

Vaccination with Afluria^® may not protect all individuals. Immunocompromised persons may have a diminished immune response. If Guillain-Barré syndrome has occurred within 6 weeks of receipt of prior influenza vaccine, the decision to give Afluria^® should be based on careful consideration of the potential benefits and risks.

Click here for full PRESCRIBING INFORMATION.